MENU
JPMA
  • Access
  • Japanese
  • About JPMA

    About JPMA Top

    • Message from the President
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • About Pharmaceuticals

    About Pharmaceuticals Top

    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee

    Information from the Committee Top

    • Code Compliance Committee
    • Pharmaceutical Industrial Policy Committee
    • Distribution Improvement Committee
    • Drug Evaluation Committee
    • Quality & Technology Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • R&D Committee
    • International Affairs Committee
    • Public Affairs Committee
    • Patient Cooperation Committee
    • ICH Project
    • APAC Project
    • Consumer Consultation Review Committee
    • Environmental Issue Committee
  • Newsletter
  • News Room

    Newsroom Top

    • News Release
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video content and advertisements
  • The Office of Pharmaceutical Industry Research
Close
JPMA

Return to Site Top

  • For Patients and the Public (About Pharmaceuticals)
    For Patients and the Public (Pharmaceuticals) Top
    • General Drug Guide
    • Clinical Trials Information
    • Together with Patients
  • Information from the Committee
    Information from the Committee Top
    • Code Compliance Committee
    • Pharmaceutical Industrial Policy Committee
    • Distribution Improvement Committee
    • Drug Evaluation Committee
    • Quality & Technology Committee
    • Biopharmaceutical Committee
    • Regulatory Affairs Committee
    • Intellectual Property Committee
    • R&D Committee
    • International Affairs Committee
    • Public Affairs Committee
    • Patient Cooperation Committee
    • ICH Project
    • APAC Project
    • Consumer Consultation Review Committee
    • Environmental Issue Committee
  • About JPMA
    About JPMA Top
    • Message from the President
    • Outline of JPMA
    • Policies and Activities
    • Voluntary Standards
    • Vision, Policy Proposals
    • Organization
    • Member Companies
  • Policies and Activities
    Policies and Activities Top
    • Business Policy, Business Plan, and Implementation Plan
    • Committee Activities
    • Convention on Biological Diversity
  • Voluntary Standards
    Voluntary Standards Top
    • Charter of Conduct
    • JPMA Code of Practice
    • Transparency Guideline for the Relation between Corporate Activities and Medical Institutions
    • Transparency Guideline for Relationships between Corporate Activities and Patient Groups
    • Guidelines for the Preparation of Product Information Summaries for Ethical Drugs (Abbreviated name: Preparation Guidelines)
    • Clinical Research
    • Basic Philosophy and Action Guidelines on Biodiversity
    • Guidelines Concerning Appropriate Competition in Japan Pharmaceutical Manufacturers Association Meetings
    • Guidelines for the Promotion of Pharmaceutical Industry in Japan
  • News Room
    Newsroom Top
    • News Release
    • JPMA Newsletter
    • Updates
    • Publications
    • Events
    • JPMA's video content and advertisements
  • The Office of Pharmaceutical Industry Research  Page will open in a new window.
  • Social Media Policy
  • Website Terms of Use
  • Vision, Policy Proposals
    Vision, Policy Proposals Top
    • Toward Realizing the JPMA's Vision for 2035
    • Chairman's Press Conference, Speeches and Comments
    • Back Number: Vision, Proposals
  • Access
  • Japanese
  • Top
  • Voluntary Standards
  • Guidelines for the Promotion of Pharmaceutical Industry in Japan

Guidelines for the Promotion of Pharmaceutical Industry in Japan

  • Guidance on Electronic Acquisition of Clinical Trial Data Supplement
  • Basic Policy on the Handling of Information Provision Pertaining to Clinical Trials
  • Guidance for Providing Information on Clinical Trials for Patients and the General Public, 3rd Edition
  • Guidance for Pandemic Influenza Preparedness
  • Items to be considered when conducting clinical trials that collect genomic samples in drug development
  • Guidance on Electronic Capture of Clinical Trial Data
  • Agreement on Provision and Transfer of Control Drugs
  • Industry Standards Manual (industry standards for the use of information related to pharmaceutical transactions between wholesalers and manufacturers)
  • Guideline for Reserch Tool Patent Licensing (Recommendations) (20KB)
  • Guideline for Reserch Tool Patent Lisensing (Proposals) (20KB)

Share this page

  • Tweet
  • Share this page

TOP

Site Search

  • Top
  • Voluntary Standards
  • Guidelines for the Promotion of Pharmaceutical Industry in Japan
  • JPMA PR and Communication Activities
  • Pharmaceutical Research Institute
  • List of Non-Financial Information Disclosure by Member Companies
  • STOP AMR
  • About JPMA
  • Policies and Activities
  • Voluntary Standards
  • Global Health
  • News Room
  • For Patients and the Public (About Pharmaceuticals)
  • Clinical Trials Information
  • Information from the Committee
  • JapanesePage will open in a new window.
  • x
  •  facebook
  •  youtube
  • Site Map
  • Website Terms of Use
  • Privacy Policy
  • Social Media Policy
  • Linking Policy
  • Accessibility Policy
  • PRAISE-NET Login

© Japan Pharmaceutical Manufacturers
Association(JPMA).

Notification

This website uses automatic translation.
The translated content may not always be fully consistent with the original Japanese content.